期刊文献+

心衰患者心脏超声改变与心肌钙调神经磷酸酶的关系 被引量:3

The relationship between echocardiaographic alternations and myocardium calcineurin activity in heart failure patients
下载PDF
导出
摘要 目的探讨心衰患者的心脏超声改变与心肌钙调神经磷酸酶(Calcineurin)活性的关系。方法以因终末期心衰做心脏移植的患者为观察对象(男14例,女1例) ,因意外死亡而作为器官移植供体者作为对照(5例均为男性)。手术前给观察组病人作心脏超声,详细记录左心室大小及收缩舒张功能等指标,并搜集供体的生前心脏超声资料。对移植下来的心脏即刻取左心室游离壁,用色度法进行Calcineurin活性测定。分析超声提供的左室资料与Calcineurin活性之间的关系。结果与对照组相比,功能衰竭的左心室肌Calcineurin活性明显升高;且左室内径越大、左室射血分数越低、左室舒张末期压力越高,Calcineurin的活性越高。结论心肌Calcineurin活性与左室形态及收缩、舒张功能有关。 Objective:To investigate the relationship between echocardiographic alternations and myocardium calcineurin activity in heart failure patients.Methods:Left ventricle free wall were obtained from explanted human failing hearts (14 male/1 female) and donor hearts (5 male) that were taken from victims of unexpected death. Colorimetric assay was applied for determine calcineurin enzymatic activity with detection of free phosphate released from a specific phospho-substrate.Record the information of left ventricle obtained from echocardiography. Analyze the relationship between calcineurin activity and left ventricle echocardiographic data, including morphology and function information.Results:There is a significant elevation of calcineurin activity in failing hearts compared with donor hearts, which were accompanied with the increased diastolic diameter (LVDD), decreased ejection fraction (LVEF), and elevated end-diastolic volume (LVEDV) of left ventricle.Conclusion:Myocardium calcineurin activity was related to the left ventricle morphology and systolic/diastolic function.
出处 《医学影像学杂志》 2005年第3期192-194,共3页 Journal of Medical Imaging
关键词 心衰 左心室 钙调神经磷酸酶 心脏超声 Heart failure Left cardiac ventricle Calcineurin Echocardiography
  • 相关文献

参考文献9

  • 1Molkentin JD, Lu JR, Antos CL,et al.A calcineurin-dependent transcriptional pathway for cardiac hypertrophy[J].Cell,1998,93:215-228.
  • 2Ritter O, Hack S, Schuh K, et al. Calcineurin in human heart hypertrophy[J].Circulation,2002,105:2265-226.
  • 3Diedrichs H, Chi M, Boelck B, et al. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure[J].Eur J Heart Fail,2004,6:3-9.
  • 4Harder KW, Owen P, Wong LK, et al. Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides[J].Biochem J,1994,298:395-401.
  • 5Hayden-Martinez K, Kane LP, Hedrick SM. Effects of a constitutively active form of calcineurin on T cell activation and thymic selection[J].J Immunol,2000,165:3713-3721.
  • 6Lautermilch NJ, Spitzer NC. Regulation of calcineurin by growth cone calcium waves controls neurite extension[J].J Neurosci,2000,20:315-325.
  • 7Guo L, Nakamura K, Lynch J, et al. Cardiac-specific expression of calcineurin reverses embryonic lethality in calreticulin-deficient mouse[J].J Biol Chem,2002,277:50776-50779.
  • 8Kjaer A, Appel J, Hildebrandt P, et al. Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects[J]. Eur J Heart Fail,2004,6:29-39.
  • 9Aronson D, Burger AJ. Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin[J].Pacing Clin Electrophysiol,2003,26:703-710.

同被引文献34

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2Zhou Z, Hu D. An epidemiological study on the preva- lence of atrial fibrillation in the Chinese population of ma- inland China [J]. J Epidemiology, 2008, 18 ( 5 ) : 209- 216.
  • 3Li H, Rao A, Hoqan P G. Interaction of calcineurin with substrates and targeting proteins [ J ]. Trends Cell Biol, 2011, 21 (2) :91-103.
  • 4Musson R E, Cobbaert C M, Smit N P. Molecular diag- nostics of calcineurin-related pathologies [ J ]. Clin Chem, 2012, 58(3) :511-522.
  • 5Wilkins B J, De Win& L J, Bueno O F, et al. Targeted disruption of NFATc3, but not NFATc4, reveals an in- trinsic defect in calcineurin-mediated cardiac hypertrophic growth[J]. Mol Cell Biol, 2002, 22 (21) :7603-7613.
  • 6Ritter O, Hack S, Schuh K, et al. Calcineurin in human heart hypertrophy [J]. Circulation, 2002, 105 ( 19 ) : 2265-2269.
  • 7Lira H W, De Win& L J, Mante J, et al. Reversal of cardiac hypertrophy in transgenic disease models by calci- neurin inhibition [J]. J Mol Cell Cardiol, 2000, 32 (4) : 697-709.
  • 8Colella M, Grisan F, Robert V, et al. Ca2+ oscillation frequency decoding in cardiac hypertrophy: role of calci- neurin/NFAT as Ca2+ signal integrators[J]. Proc Nati Acad Sci U S A, 2008, 105(8) :2859-2864.
  • 9Lin C C, Lin J L, Lin C S, et al. Activation of the calcineurin-nuclear factor of activated T cell signal transduc- t.ion pathway in atrial fibrillation[J]. Chest, 2004, 126 (6) : 1926-1932.
  • 10Qi X Y, Yeh Y H, Xiao L, et al. Cellular signaling un- derlying atrial tachycardia remodeling of L-type calcium current[J]. Circ Res, 2008, 103(8) :845-854.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部